(Arylamidoanilino)nitroethylene compounds

Details (Arylamidoanilino)nitroethylene compounds (Arylamidoanilino)nitroethylene compounds

2005-09-15

2009-11-17

Andres, Janet L (Department: 1625)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Heterocyclic carbon compounds containing a hetero ring...

C544S128000, C546S165000, C546S166000, C514S314000, C514S311000

Reexamination Certificate

active

07618965

ABSTRACT:
Compounds represented by Formula (I):or a pharmaceutically acceptable salt or N-oxide thereof, wherein A, Q, Y, R1, R2, and R5are defined herein, are useful in the treatment of tumors and cancers such as mastocytosis/mast cell leukemia, gastrointestinal stromal tumors (GIST), germ cell tumors, small cell lung carcinoma (SCLC), sinonasal natural killer/T-cell lymphoma, testicular cancer (seminoma), thyroid carcinoma, malignant melanoma, ovarian carcinoma, adenoid cystic carcinoma, acute myelogenous leukemia (AML), breast carcinoma, pediatric T-cell acute lymphoblastic leukemia, neuroblastoma, mast cell leukemia, angiosarcoma, anaplastic large cell lymphoma, endometrial carcinoma, and prostate carcinoma.

REFERENCES:
patent: 2002/0016461 (2002-02-01), Albers
patent: WO 2004/063330 (2004-07-01), None

Affiliated with

Also associated with

Rating

(Arylamidoanilino)nitroethylene compounds does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with (Arylamidoanilino)nitroethylene compounds, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and (Arylamidoanilino)nitroethylene compounds will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4080543